In vitro analysis of inflammatory responses following environmental exposure to pharmaceuticals and inland waters

Science of the Total Environment

Volumn 407, Issue 4, 2009, Pages 1452-1460

  Khalaf, Hazem ^a   Salste, Lotta ^b   Karlsson, Patrik ^b   Ivarsson, Per ^c   Jass, Jana ^a   Olsson, Per Erik ^a  

^a ÖREBRO UNIVERSITY   (Sweden)

^b Research and Development   (Sweden)

^c Sweden   (Sweden)

Author keywords

Activator protein 1 (AP 1); Inflammation; Non steroidal anti inflammatory drugs; Nuclear factor B (NF B); Pharmaceuticals

Indexed keywords

CHEMICAL ACTIVATION; ESCHERICHIA COLI; SEWAGE; SEWAGE TREATMENT; SEWAGE TREATMENT PLANTS; WATER TREATMENT;

ACTIVATOR PROTEIN-1 (AP-1); ATENOLOL; BLADDER EPITHELIAL CELLS; DEXTROPROPOXYPHENE; DICLOFENAC; E. COLI; ENVIRONMENTAL EXPOSURES; FUROSEMIDE; HUMAN RISKS; IN VITRO; INFLAMMATION; INFLAMMATORY DRUGS; INFLAMMATORY RESPONSES; INLAND WATERS; JURKAT CELLS; KETOPROFEN; NAPROXEN; NON-STEROIDAL ANTI-INFLAMMATORY DRUGS; PHARMACEUTICAL MIXTURES; PHARMACEUTICALS; T-CELLS; TRIMETHOPRIM; UNKNOWN SUBSTANCES; WATER SAMPLES;

DRUG PRODUCTS;

ATENOLOL; CITALOPRAM; CYCLOPHOSPHAMIDE; DEXTROPROPOXYPHENE; DICLOFENAC; ERYTHROMYCIN; FUROSEMIDE; HYDROCHLOROTHIAZIDE; IBUPROFEN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; KETOPROFEN; METOPROLOL; NAPROXEN; OXAZEPAM; PARACETAMOL; RANITIDINE; SALBUTAMOL; SIMVASTATIN; SULFADIMIDINE; TRIMETHOPRIM; WARFARIN;

ANTIBIOTICS; BACTERIUM; CONCENTRATION (COMPOSITION); PROTEIN; WATER POLLUTION;

ARTICLE; CONTROLLED STUDY; DOWN REGULATION; ENVIRONMENTAL EXPOSURE; HUMAN; HUMAN CELL; IN VITRO STUDY; INFLAMMATION; PRIORITY JOURNAL; WATER ANALYSIS;

CELL LINE, TUMOR; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; HUMANS; INFLAMMATION; JURKAT CELLS; NF-KAPPA B; PHARMACEUTICAL PREPARATIONS; RIVERS; SOLID PHASE EXTRACTION; SWEDEN; TRANSCRIPTION FACTOR AP-1; WATER POLLUTANTS, CHEMICAL; XENOBIOTICS;

BORAS; EURASIA; EUROPE; NORTHERN EUROPE; SCANDINAVIA; SWEDEN; VASTRA GOTALAND;

ESCHERICHIA COLI;

EID: 57049179481     PISSN: 00489697     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.scitotenv.2008.10.016     Document Type: Article

References (40)

1. Antonic J., and Heath E. Determination of NSAIDs in river sediment samples. Anal Bioanal Chem 387 (2007) 1337-1342
2. Bendz D., Paxeus N.A., Ginn T.R., and Loge F.J. Occurrence and fate of pharmaceutically active compounds in the environment, a case study: Hoje River in Sweden. J Hazard Mater 122 (2005) 195-204
3. Cleuvers M. Mixture toxicity of the anti-inflammatory drugs diclofenac, ibuprofen, naproxen, and acetylsalicylic acid. Ecotoxicol Environ Saf 59 (2004) 309-315
4. Cleuvers M. Initial risk assessment for three beta-blockers found in the aquatic environment. Chemosphere 59 (2005) 199-205
5. Cryer B., and Feldman M. Cyclooxygenase-1 and cyclooxygenase-2 selectivity of widely used nonsteroidal anti-inflammatory drugs. Am J Med 104 (1998) 413-421
6. Della Greca M., Iesce M.R., Previtera L., Rubino M., and Temussi F. A new photoproduct of the drug furosemide in aqueous media. Environ Chem Lett 2 (2004) 155-158
7. Dinarello C.A. Proinflammatory cytokines. Chest 118 (2000) 503-508
8. Dubois R.N., Abramson S.B., Crofford L., Gupta R.A., Simon L.S., Van De Putte L.B., et al. Cyclooxygenase in biology and disease. FASEB J 12 (1998) 1063-1073
9. Ebinu J.O., Stang S.L., Teixeira C., Bottorff D.A., Hooton J., Blumberg P.M., et al. RasGRP links T-cell receptor signaling to Ras. Blood 95 (2000) 3199-3203
10. Faure M., Voyno-Yasenetskaya T.A., and Bourne H.R. cAMP and beta gamma subunits of heterotrimeric G proteins stimulate the mitogen-activated protein kinase pathway in COS-7 cells. J Biol Chem 269 (1994) 7851-7854
11. Fent K., Weston A.A., and Caminada D. Ecotoxicology of human pharmaceuticals. Aquat Toxicol 76 (2006) 122-159
12. Halling-Sorensen B., Nors Nielsen S., Lanzky P.F., Ingerslev F., Holten Lutzhoft H.C., and Jorgensen S.E. Occurrence, fate and effects of pharmaceutical substances in the environment - a review. Chemosphere 36 (1998) 357-393
13. Handel M.L., Watts C.K., deFazio A., Day R.O., and Sutherland R.L. Inhibition of AP-1 binding and transcription by gold and selenium involving conserved cysteine residues in Jun and Fos. Proc Natl Acad Sci U S A 92 (1995) 4497-4501
14. Harizi H., Juzan M., Pitard V., Moreau J.F., and Gualde N. Cyclooxygenase-2-issued prostaglandin e(2) enhances the production of endogenous IL-10, which down-regulates dendritic cell functions. J Immunol 168 (2002) 2255-2263
15. Hoeger B., Kollner B., Dietrich D.R., and Hitzfeld B. Water-borne diclofenac affects kidney and gill integrity and selected immune parameters in brown trout (Salmo trutta f. fario). Aquat Toxicol 75 (2005) 53-64
16. Hung J.H., Su I.J., Lei H.Y., Wang H.C., Lin W.C., Chang W.T., et al. Endoplasmic reticulum stress stimulates the expression of cyclooxygenase-2 through activation of NF-kappaB and pp38 mitogen-activated protein kinase. J Biol Chem 279 (2004) 46384-46392
17. Hwang D., Jang B.C., Yu G., and Boudreau M. Expression of mitogen-inducible cyclooxygenase induced by lipopolysaccharide: mediation through both mitogen-activated protein kinase and NF-kappaB signaling pathways in macrophages. Biochem Pharmacol 54 (1997) 87-96
18. Isidori M., Nardelli A., Parrella A., Pascarella L., and Previtera L. A multispecies study to assess the toxic and genotoxic effect of pharmaceuticals: furosemide and its photoproduct. Chemosphere 63 (2006) 785-793
19. Jorgensen S.E., and Halling-Sorensen B. Drugs in the environment. Chemosphere 40 (2000) 691-699
20. Kang G., Kong P.J., Yuh Y.J., Lim S.Y., Yim S.V., Chun W., et al. Curcumin suppresses lipopolysaccharide-induced cyclooxygenase-2 expression by inhibiting activator protein 1 and nuclear factor kappab bindings in BV2 microglial cells. J Pharmacol Sci 94 (2004) 325-328
21. Kummerer K. Drugs in the environment: emission of drugs, diagnostic aids and disinfectants into wastewater by hospitals in relation to other sources - a review. Chemosphere 45 (2001) 957-969
22. Kummerer K. Significance of antibiotics in the environment. J Antimicrob Chemother 52 (2003) 5-7
23. Kummerer K. Resistance in the environment. J Antimicrob Chemother 54 (2004) 311-320
24. Kwon O., Lee E., Moon T.C., Jung H., Lin C.X., Nam K.S., et al. Expression of cyclooxygenase-2 and pro-inflammatory cytokines induced by 2,2′,4,4′,5,5′-hexachlorobiphenyl (PCB 153) in human mast cells requires NF-kappa B activation. Biol Pharm Bull 25 (2002) 1165-1168
25. Maurer M., Escher B.I., Richle P., Schaffner C., and Alder A.C. Elimination of beta-blockers in sewage treatment plants. Water Res 41 (2007) 1614-1622
26. Mitchell J.A., Akarasereenont P., Thiemermann C., Flower R.J., and Vane J.R. Selectivity of nonsteroidal antiinflammatory drugs as inhibitors of constitutive and inducible cyclooxygenase. Proc Natl Acad Sci U S A 90 (1993) 11693-11697
27. Nikolai L.N., McClure E.L., Macleod S.L., and Wong C.S. Stereoisomer quantification of the beta-blocker drugs atenolol, metoprolol, and propranolol in wastewaters by chiral high-performance liquid chromatography-tandem mass spectrometry. J Chromatogr A 1131 (2006) 103-109
28. Oaks J.L., Gilbert M., Virani M.Z., Watson R.T., Meteyer C.U., Rideout B.A., et al. Diclofenac residues as the cause of vulture population decline in Pakistan. Nature 427 (2004) 630-633
29. Riendeau D., Charleson S., Cromlish W., Mancini J.A., Wong E., and Guay J. Comparison of the cyclooxygenase-1 inhibitory properties of nonsteroidal anti-inflammatory drugs (NSAIDs) and selective COX-2 inhibitors, using sensitive microsomal and platelet assays. Can J Physiol Pharm 75 (1997) 1088-1095
30. Schmidt A.S., Bruun M.S., Dalsgaard I., Pedersen K., and Larsen J.L. Occurrence of antimicrobial resistance in fish-pathogenic and environmental bacteria associated with four Danish rainbow trout farms. Appl Environ Microbiol 66 (2000) 4908-4915
31. Schwaiger J., Ferling H., Mallow U., Wintermayr H., and Negele R.D. Toxic effects of the non-steroidal anti-inflammatory drug diclofenac. Part I: histopathological alterations and bioaccumulation in rainbow trout. Aquat Toxicol 68 (2004) 141-150
32. Schwartz T., Kohnen W., Jansen B., and Obst U. Detection of antibiotic-resistant bacteria and their resistance genes in wastewater, surface water, and drinking water biofilms. FEMS Microbiol Ecol 43 (2003) 325-335
33. Shultz S., Baral H.S., Charman S., Cunningham A.A., Das D., Ghalsasi G.R., et al. Diclofenac poisoning is widespread in declining vulture populations across the Indian subcontinent. Proc Biol Sci 271 Suppl 6 (2004) S458-S460
34. Southall M.D., Michael R.L., and Vasko M.R. Intrathecal NSAIDS attenuate inflammation-induced neuropeptide release from rat spinal cord slices. Pain 78 (1998) 39-48
35. Turi J.L., Jaspers I., Dailey L.A., Madden M.C., Brighton L.E., Carter J.D., et al. Oxidative stress activates anion exchange protein 2 and AP-1 in airway epithelial cells. Am J Physiol Lung Cell Mol Physiol 283 (2002) L791-L798
36. Wagner M., Klein C.L., Kleinert H., Euchenhofer C., Forstermann U., and Kirkpatrick C.J. Heavy metal ion induction of adhesion molecules and cytokines in human endothelial cells: the role of NF-kappaB, I kappaB-alpha and AP-1. Pathobiology 65 (1997) 241-252
37. West M.A., Bennet T., Seatter S.C., Clair L., and Bellingham J. LPS pretreatment reprograms macrophage LPS-stimulated TNF and IL-1 release without protein tyrosine kinase activation. J Leukoc Biol 61 (1997) 88-95
38. Zuccato E., Calamari D., Natangelo M., and Fanelli R. Presence of therapeutic drugs in the environment. Lancet 355 (2000) 1789-1790
39. Zuccato E., Castiglioni S., and Fanelli R. Identification of the pharmaceuticals for human use contaminating the Italian aquatic environment. J Hazard Mater 122 (2005) 205-209
40. Zuccato E., Castiglioni S., Fanelli R., Reitano G., Bagnati R., Chiabrando C., et al. Pharmaceuticals in the environment in Italy: causes, occurrence, effects and control. Environ Sci Pollut Res Int 13 (2006) 15-21